Pemphigus Vulgaris Market to Reach $2.79 Billion by 2030 at 7.5% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Pemphigus Vulgaris Market From 2026 To 2030?

The pemphigus vulgaris market has experienced substantial expansion in recent years. It is anticipated to grow from $1.94 billion in 2025 to $2.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.7%. The market’s historical growth can be ascribed to factors such as limited awareness and delayed diagnosis, a strong reliance on corticosteroids, inadequate access to dermatology specialists, the elevated cost of immunosuppressive therapies, and fragmented clinical data and registries.

The pemphigus vulgaris market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This expansion during the forecast period is fueled by factors such as the increasing embrace of targeted immunotherapies, a greater reliance on biologics and monoclonal antibodies, the expansion of teledermatology and remote monitoring solutions, progress in early detection diagnostic tools, and heightened patient awareness and support initiatives. Key trends expected during this period involve the rising application of AI for early diagnosis and predicting prognosis, a growing shift towards genomics-based personalized therapies, the integration of cloud computing and big data for managing patient information, the deployment of IoT-enabled devices for distant patient monitoring, and the adoption of smart manufacturing processes in the production of immunosuppressive drugs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22094&type=smp

What Key Factors Are Affecting The Pemphigus Vulgaris Market Demand?

The growing occurrence of autoimmune diseases is anticipated to drive the expansion of the pemphigus vulgaris market in the foreseeable future. These disorders involve the immune system mistakenly attacking and causing damage to the body’s own healthy cells, tissues, or organs. The incidence of autoimmune diseases is on the rise, influenced by factors such as genetic predisposition, environmental triggers, and evolving lifestyle habits. Genetic elements play a crucial role, as individuals with a family history of autoimmune conditions are more susceptible due to inherited weaknesses in their immune systems. As autoimmune diseases become more widespread due to these genetic, environmental, and lifestyle influences, a greater number of people are being diagnosed with conditions like pemphigus vulgaris, thereby increasing the demand for advanced treatments. For instance, in January 2025, the Mayo Clinic Health System, a US-based network of community-based medical facilities that provides comprehensive healthcare services, indicated that the global incidence and prevalence of autoimmune diseases are increasing, with yearly rises estimated at 19.1% and 12.5%, respectively. Consequently, the rising prevalence of autoimmune diseases is fostering the growth of the pemphigus vulgaris market.

How Is The Pemphigus Vulgaris Market Segmented Across Different Segment Categories?

The pemphigus vulgaris market covered in this report is segmented –

1) By Diagnosis And Treatment: Diagnosis, Treatment

2) By Population Type: Pediatric, Adults, Geriatric

3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR)

2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy

What Trends Are Influencing Changes In The Pemphigus Vulgaris Market?

Leading companies operating within the pemphigus vulgaris market are prioritizing financial strategies to boost treatment effectiveness and expand available therapeutic options. These investment solutions encompass the allocation of financial resources and strategic approaches towards the development of treatments, research efforts, and their subsequent market introduction. For instance, in January 2023, the Patient Access Network Foundation (PAN) Foundation, a US-based non-profit organization, introduced a financial assistance program designed to offer up to $6,600 annually to eligible patients suffering from pemphigus vulgaris, helping to cover deductibles, copays, and coinsurance costs. To qualify for this financial aid, patients must be undergoing treatment for pemphigus vulgaris, possess Medicare health insurance that covers their essential medications, and have an income level at or below 400% of the federal poverty level. Additionally, the PAN Foundation extends support through transportation assistance and by connecting patients with relevant support organizations.

Which Organizations Play A Role In The Pemphigus Vulgaris Market Landscape?

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation

Get The Full Pemphigus Vulgaris Market Report:

https://www.thebusinessresearchcompany.com/report/pemphigus-vulgaris-global-market-report

Which Region Represents The Largest Share Of The Pemphigus Vulgaris Market?

North America was the largest region in the pemphigus vulgaris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pemphigus vulgaris market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pemphigus Vulgaris Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pemphigus-vulgaris-global-market-report

Browse Through More Reports Similar to the Global Pemphigus Vulgaris Market 2026, By The Business Research Company

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Uterine Fibroids Treatment Market Report

https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report

Chlamydia Infection Treatment Market Report

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795